Cowen & Co
STAMFORD, Conn. and WESTON, Mass., Nov. 6 /PRNewswire/ -- Those biopharmaceutical companies that are able to incorporate innovative and flexible elements into their business models will be best positioned to survive healthcare reform and maintain attractive long-term returns, according to a white paper published today by Cowen Healthcare Royalty Partners, a global healthcare private equity firm, and Health Advances, a leading healthcare strategy firm. The paper, "Maintaining Attractive Biopharma Returns in the Face of Healthcare Reform", examines key issues at the center of the debate including access to care, controlling costs, drug pricing and value-based healthcare. In addition to discussing ...
The IPO for STR Holdings, Inc. (NYSE: STRI) is open for trading. Shares are trading at $10.92 after pricing 12,300,000 shares at $10.00 per share, below the expected range ...
ENFIELD, Conn.--(BUSINESS WIRE)-- STR Holdings, Inc. (NYSE: STRI) today announced that the initial public offering of 12,300,000 shares of its common stock has been priced at $10.00 per share. The shares began trading today on The New York Stock Exchange under the ticker symbol "STRI." The closing of the offering is expected to take place on November 12. Of the shares being sold, 3,300,000 are being offered by the Company and 9,000,000 shares are being offered by selling stockholders. In addition ...
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Nov. 6, 2009) - Petaquilla Minerals Ltd. ("Petaquilla" or the "Company") (TSX: PTQ)(OTCBB: PTQMF)(FRANKFURT: P7Z) is pleased to announce that Mr. Joao Manuel has been appointed as the Company's President and Chief Executive Officer. Mr. Manuel joined the Company in December 2008 as its Chief Operating Officer after serving as the Chief Financial Officer of Petaquilla Copper Ltd. He will be leading the Company into its future production development phases and the continued exploration of the Petaquilla mining district where it owns a 100% interest in several large mineral concessions adjacent to the Molejon gold mine site. Additionally he will focus on the creation of shareholder value through the spin-off of the Company's fully owned subsidiary, Petaquilla Infrastructure Ltd., which was incorporated for the construction, operation and management of infrastructure facilities required for the development of the mining industry in Panama. The Company ...
VANCOUVER, BRITISH COLUMBIA -- (MARKET WIRE) -- 11/06/09 -- Petaquilla Minerals Ltd. ("Petaquilla" or the "Company") (TSX: PTQ)(OTCBB: PTQMF)(FRANKFURT: P7Z) is pleased to announce that Mr. Joao Manuel has been appointed as the Company's President and Chief Executive Officer. Mr. Manuel joined the Company in December 2008 as its Chief Operating Officer after serving as the Chief Financial Officer of Petaquilla Copper Ltd. He will be leading the Company into its future production development phases and the continued exploration of the Petaquilla mining district where it owns a 100% interest in several large mineral concessions adjacent to the Molejon gold mine site. Additionally he will focus on the creation of shareholder value through the spin-off of the Company's fully owned subsidiary, Petaquilla Infrastructure Ltd., which was incorporated for the construction, operation and management of ...
-
Cowen Group, Inc. (COWN) Chairman and Chief Executive Officer To Ring The NASDAQ Stock Market Opening Bell
-
China Integrated Energy, Inc. Announces Closing of Public Offering of Five Million Shares of Common Stock
-
Form 8-K Cowen Holdings, Inc. For: Nov 02
-
Form 8-K COWEN GROUP, INC. For: Nov 02
-
Eurand Reports Key Achievements and Strong Revenue Growth for Third Quarter 2009
-
Form 4 COWEN GROUP, INC. For: Nov 02 Filed by: STARK MORGAN B
-
Form 4 COWEN GROUP, INC. For: Nov 02 Filed by: RCG HOLDINGS LLC
-
Cowen & Co Downgrades GTx, Inc (GTXI) to Underperform
-
Ramius and Cowen (COWN) Complete Business Combination
-
Ramius and Cowen Group Announce Completion of Business Combination
-
Rubio's(R) Restaurants, Inc. Rejects Meruelo Group Proposal and Announces Plan to Evaluate Strategic Alternatives
-
Cowen Launches New Financial Institutions Group
-
Thomas Weisel Partners Group Reports 2009 Third Quarter Results
-
Cowen & Co Initiates Coverage on NVIDIA (NVDA) with a Neutral
-
TEDxMidAtlantic Expected to Be 100% Full
-
Cowen & Co Downgrades Xenoport (XNPT) to Neutral
-
Cowen & Co Upgrades Incyte (INCY) to Outperform
-
China BAK Announces Closing of a $20.6 Million Registered Direct Offering
-
Eurand Completes Public Offering, Including Exercise of the Underwriters' Over-Allotment Option, for Total Net Proceeds of Approximately $103.9 Million
-
GSI Commerce to Acquire Retail Convergence and Enter Private Sale Space with Addition of Rue La La
-
Delcath Systems (DCTH) Announces 8.5M Common Stock Offering
-
Delcath Systems, Inc. Announces Public Offering of Common Stock
-
Cowen & Co Initiates Coverage on Qiagen (QGEN) with an Outperform
-
Laterooms and Octopus Travel Top Greenlight's Integrated Search Report For the Hotel Sector
-
Company Profile for The Cowen Group
-
Cowen & Co Initiates Coverage on Natural and Organic Foods Stocks
-
Morning Movers 10/22: HTE, SDXC, SXI, NYT, FFIV, SKX, JCG Higher; TQNT, WSTL, NWK, EPAX, AFFX, NCR Lower
-
Cowen & Co Upgrades J. Crew Group (JCG) to Neutral
-
Eurand Announces Pricing of Offering of Ordinary Shares
-
China BAK to Raise $20.6 Million in Registered Direct Offering
-
Pharmos Corporation Engages Cowen to Assist the Company with Accelerating a Partnership for Dextofisopam
-
Notable Analyst Rating Changes 10/21: CAT, CSCO, SYK, FRX Upgraded; LMT, EAT, NVS Downgraded
-
Cowen & Co Upgrades Forest Laboratories (FRX) to Outperform
-
Cowen Group Q3 Staffing Report Released
-
Amarin Announces Completion of $70 Million Private Placement
-
Eurand Announces Proposed Public Offering of Ordinary Shares
-
Two Independent Surveys Find Clearwell Systems the Leader in Early Case Assessment
-
Dyax Announces New Developments Related to Phage Display-Discovered Drug Candidates
-
Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
-
Cowen Downgrades Onyx Pharma (ONXX) to Market Perform
-
Notable Analyst Rating Changes 10/12: BNI, MA, V, BBW, AMD, KR, PCG Upgrade; SNDK, OXY, NOK, LMT, BIDU Downgrade
-
David Moenning's Daily State of the Markets: Subtle, Yet Effective
-
Cowen & Co Downgrades Lockheed Martin (LMT) to Neutral
-
Cowen & Co Downgrades AstraZeneca (AZN) to Neutral
-
Notable Analyst Rating Changes 10/9: VIA, AKS, SY, MAR, RIMM; ARO, MT, BMY, LTD Downgrade
-
Cowen & Co Downgrades Bristol-Myers (BMY) to Neutral
-
David Moenning's Daily State of the Markets: A Day In The Life
-
Cowen & Co Upgrades Novartis (NVS) to Outperform
-
Cowen & Co Upgrades American Eagle Outfitters (AEO) to Neutral
-
Keefe, Bruyette & Woods Maintains an 'Outperform' on Cowen & Company (COWN); Adjusts Estimates & PT
